About Glenmark Pharmaceuticals Limited (GLENMARK)
Glenmark Pharmaceuticals Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector.
GLENMARK trades on the Indian stock exchanges (NSE/BSE) and is classified as a large-cap stock .
Key Statistics
- Current Price
- ₹2,091.80
- Market Cap
- ₹590.51B
- 52-Week High
- ₹2,297.90
- 52-Week Low
- ₹1,336.00
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
₹1,000 Invested in Glenmark Pharmaceuticals Limited (GLENMARK)
How much would ₹1,000 invested in GLENMARK be worth today?
What would ₹1,000 invested in GLENMARK 1 year ago be worth today?
A ₹1,000 investment in Glenmark Pharmaceuticals Limited (GLENMARK) in 2025 would be worth ₹1,434 as of May 2026, representing a +43.5% total return.
What would ₹1,000 invested in GLENMARK 3 years ago be worth today?
A ₹1,000 investment in Glenmark Pharmaceuticals Limited (GLENMARK) in 2023 would be worth ₹4,955 as of May 2026, representing a +395.5% total return.
What would ₹1,000 invested in GLENMARK 5 years ago be worth today?
A ₹1,000 investment in Glenmark Pharmaceuticals Limited (GLENMARK) in 2021 would be worth ₹4,505 as of May 2026, representing a +350.5% total return.
What would ₹1,000 invested in GLENMARK 10 years ago be worth today?
A ₹1,000 investment in Glenmark Pharmaceuticals Limited (GLENMARK) in 2016 would be worth ₹2,770 as of May 2026, representing a +177.0% total return.
What would ₹1,000 invested in GLENMARK at IPO be worth today?
A ₹1,000 investment in Glenmark Pharmaceuticals Limited (GLENMARK) at IPO would be worth ₹7,106,917 as of May 2026, representing a +710591.7% total return.
Monthly Returns Heatmap
Over the past 23+ years (285 months), Glenmark Pharmaceuticals Limited (GLENMARK) has averaged a monthly return of +5.34% with a median return of +1.79%. The stock had 166 positive months (58%) and 119 negative months (42%). The best month in GLENMARK's history was October 2003 with a +449.9% return, while the worst was January 2009 at -53.6%. Historically, October tends to be the strongest month (averaging +18.3%), and January the weakest (-6.5%).
GLENMARK's longest winning streak was 10 consecutive months of gains, while its longest losing streak was 8 consecutive months of losses. The best full year was 2003 with a cumulative return of +686.6%, and the worst was 2019 at -62.2%.
Annual Returns
Over 24 years of trading history, Glenmark Pharmaceuticals Limited (GLENMARK) has delivered an average annual return of +158.79% with a median return of +23.36%. The compound annual growth rate (CAGR) is +41.09%. The stock posted gains in 17 years (71%) and losses in 7 years (29%).
GLENMARK's best year was 2003 with a +2854.36% gain, while the worst was 2008 at -50.32%. The longest streak of consecutive positive years was 5, and the longest losing streak was 2 years. GLENMARK achieved double-digit gains (10%+) in 14 years. It suffered double-digit losses in 5 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +2.78% | ₹2,035.20 | ₹2,091.80 |
| 2025 | +26.79% | ₹1,605.16 | ₹2,035.20 |
| 2024 | +88.70% | ₹850.64 | ₹1,605.16 |
| 2023 | +101.92% | ₹421.27 | ₹850.64 |
| 2022 | -19.23% | ₹521.59 | ₹421.27 |
| 2021 | +7.61% | ₹484.71 | ₹521.59 |
| 2020 | +42.75% | ₹339.55 | ₹484.71 |
| 2019 | -49.59% | ₹673.56 | ₹339.55 |
| 2018 | +16.87% | ₹576.33 | ₹673.56 |
| 2017 | -32.84% | ₹858.14 | ₹576.33 |
| 2016 | -3.40% | ₹888.33 | ₹858.14 |
| 2015 | +19.93% | ₹740.70 | ₹888.33 |
| 2014 | +44.79% | ₹511.58 | ₹740.70 |
| 2013 | +1.34% | ₹504.80 | ₹511.58 |
| 2012 | +81.01% | ₹278.88 | ₹504.80 |
| 2011 | -18.84% | ₹343.60 | ₹278.88 |
| 2010 | +31.45% | ₹261.39 | ₹343.60 |
| 2009 | -6.67% | ₹280.08 | ₹261.39 |
| 2008 | -50.32% | ₹563.76 | ₹280.08 |
| 2007 | +297.17% | ₹141.94 | ₹563.76 |
| 2006 | +93.06% | ₹73.52 | ₹141.94 |
| 2005 | +29.98% | ₹56.56 | ₹73.52 |
| 2004 | +251.36% | ₹16.10 | ₹56.56 |
| 2003 | +2854.36% | ₹0.54 | ₹16.10 |
Frequently Asked Questions: GLENMARK
What sector is GLENMARK in? ▼
GLENMARK operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has GLENMARK performed historically? ▼
Over 24 years of trading history, GLENMARK has posted gains in 17 years (71% of the time). The best year was 2003 with a +2854.4% return. Past performance does not guarantee future results.
How can I invest in GLENMARK? ▼
You can invest in GLENMARK through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold GLENMARK.
Last updated: 4/4/2026